Verana Health has launched a groundbreaking dataset named Qdata Cataract, providing deep insights into cataract surgery outcomes drawn from a pool of more than 9 million patients. With an average patient follow-up of nearly four years, the dataset is poised to significantly aid in the development of new drugs and treatment strategies for cataract-related conditions.
Cataracts, a condition where the eye’s lens becomes clouded over time, remain the leading cause of vision impairment globally. In the U.S. alone, nearly 3 million cataract surgeries are performed annually, making it one of the most routine and successful surgical procedures.
Despite the high success rate, real-world data on cataract surgery outcomes, intraocular lens (IOL) selection, and patient experiences have been limited and inconsistent—until now.
“While cataract surgery is highly successful, real-world insights into surgical outcomes, lens selection, and patient experiences remain fragmented,” said Sujay Jadhav, CEO of Verana Health. “Qdata Cataracts delivers a new level of clarity, equipping life sciences companies with high-quality evidence to advance clinical research, improve outcomes, reduce complications, and enhance intraocular lens technology.”
Qdata Cataract is powered by the American Academy of Ophthalmology’s IRIS Registry, the largest specialty society clinical data registry in the world. The dataset features essential variables such as visual acuity, intraocular pressure, and IOL brand and model, making it a valuable tool for research, health economics, and strategic planning.
This dataset enables cohort identification, patient stratification, and real-world outcome analysis, offering new opportunities to assess surgical results, compare responses to different IOL models, and evaluate overall treatment effectiveness.
Qdata Cataract can be used across a range of applications including:
- Clinical trial optimization through identification of practices treating cataract patients.
- Health economics and outcomes research (HEOR) to assess treatment patterns and patient outcomes.
- Commercialization efforts by refining market insights.
With this new resource, Verana Health aims to bring precision and innovation to cataract treatment strategies, improving outcomes for millions of patients.
Related topics:
